BioSpace News Archive

Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx ® plant cell-based protein expression system, today announced that it has rescheduled today’s conferenc

Advanced diagnostics company Prime Genomics, announced former DigitalDx EIR Robert Weigle joins as CEO, bringing over 25 years of experience building healthcare businesses.

TreeFrog Therapeutics, a French biotech company developing a disruptive technology for the mass-production of safe and affordable cell therapies, received the prestigious Prix Galien MedStartup on October 26th, during a virtual ceremony held in Boston. Laureate of the “Biopharmaceutical Industry” category, TreeFrog was rewarded for its collaboration with the Harvard Stem Cell Institute and the Dana-Farber Cancer Institute as part of the QC-Stem project.

Recruitment is underway for volunteers for the phase 3 trial of the Oxford University – AstraZeneca COVID-19 vaccine at UCLA Health which joins other medical centers nationwide as part of the study effort .

Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) today announced it will release financial results for the third quarter of 2020 after market close on Thursday, November 12, 2020.

MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or the “Company”), an industry leader in advanced wound care and a therapeutic biologics company, today announced that it will report financial results for the third quarter ended September 30, 2020 after the market close on Wednesday, November 4, 2020.

Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), today announced it will release its financial results for the third quarter of 2020 after market close on Thursday, November 12, 2020.

Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and business highlights for the second quarter ended September 30, 2020

Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Today at 4:30 p.m. ET

United Spinal Association announced Vincenzo Piscopo, an experienced professional in diversity, inclusion and social causes, has been appointed president and CEO by the organization’s board of directors.